ClinicalTrials.Veeva

Menu

The Effects of IMT on Physical Activity and Quality of Life in LTx Candidates

M

Medipol Health Group

Status

Completed

Conditions

Lung Transplantation
Inspiratory Muscle Training

Treatments

Other: Pulmonary rehabilitation
Other: Inspiratory muscle training

Study type

Interventional

Funder types

Other

Identifiers

NCT03584620
IMT_LTx_PA_QOL

Details and patient eligibility

About

Inspiratory Muscle Training (IMT), which is used to strengthen the respiratory muscles, is one of the techniques used in PR. It is mostly used in patients with chronic obstructive pulmonary disease, and has been shown to be beneficial for functionality and also for relieving dyspnea perception. It is reported in the guidelines that IMT has additional benefit for endurance in COPD patients. However, there are no studies related to its use and effectiveness in lung transplantation. In this study, investigators hoped to increase these known benefits by adding IMT to the standard Pulmonary Rehabilitation.

There are two main objectives of this study:

  • to examine the effect of inspiratory muscle training on physical activity status and quality of life in lung transplantation candidates,
  • to compare physical activity and quality of life changes between the IMT+PR group and the PR group

Full description

The patients in the lung transplantation waiting list were included the study. These patients were with severe lung disease requiring transplantation, and that the intervention was undertaken before any lung transplantation. The patients were eligible for inclusion if participitants have: a diagnosis of terminally severe lung disease, being listed for lung transplantation, medically stable, had no orthopedic or cardiac problems that would prevent them from exercising and had no transfer problem to the PR centre.

Participants who meet the study inclusion criteria and complete the baseline assessments were randomly allocated into one of the two groups: namely Pulmonary Rehabilitation plus Inspiratory Muscle Training Group (IMT+PR) or Pulmonary Rehabilitation Group (PR) using a numbered series of 34 prefilled envelops specifying group assignment generated by a computer-based program.

All patients underwent supervised PR program on 2 days per week for 3 months. Apart from that, participitant were asked to perform the home exercise program which was scheduled as 3 days per week and fill out the exercise follow-up form. The study group was provided with IMT in addition to the standard program.

Enrollment

34 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • a diagnosis of terminally severe lung disease,
  • being listed for lung transplantation,
  • medically stable,
  • had no orthopedic or cardiac problems that would prevent them from exercising
  • had no transfer problem to the PR centre.

Exclusion criteria

  • Malignancy in the last 2 years,
  • Other advanced major organ / system dysfunction that can not be treated outside the lung,
  • Untreated non-pulmonary infection,
  • Disputed medical treatment discontinuity,
  • Untreatable psychiatric illness or psychosocial condition that interferes with treatment compliance,
  • No appropriate, reliable social support,

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

34 participants in 2 patient groups

IMT+PR Group
Experimental group
Description:
Patients received a 3-month standard hospital-based Pulmonary Rehabilitation included aerobic and strength training. In addition standard pulmonary rehabilitation, patients received inspiratory muscle training.
Treatment:
Other: Pulmonary rehabilitation
Other: Inspiratory muscle training
PR group
Experimental group
Description:
Patients received a 3-month standard hospital-based Pulmonary Rehabilitation included aerobic and strength training.
Treatment:
Other: Pulmonary rehabilitation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems